Williams Racing Announces Partnership With Dorilton Ventures

Williams Racing is pleased to announce Dorilton Ventures as an Official Partner of the Team. Dorilton Ventures leads significant minority investments in early to mid-stage technology companies focused on data-centric segments such as enterprise IT infrastructure, data science, and cyber security.

The partnership will see Williams Racing support Dorilton Ventures across its investments, enabling growth in these companies whilst developing synergies with the fast-paced world of Formula One. The partnership is yet another signpost of the new commercial direction at Williams, focused on utilising the high-performance culture that exists at Grove to help deliver added value to our partners businesses beyond typical marketing benefits.

Dorilton Ventures has made multiple investments to date, including multi-lingual, geo-enabled social media and web-monitoring platform Babel Street; space-based radio frequency analytics specialist Hawkeye360; healthcare analytics platform Post-Acute Analytics; and personalized tissue therapeutics company XenoTherapeutics.

Dorilton Ventures branding will appear on the FW43B at this weekend’s Portuguese Grand Prix (30^th April – 2^nd May) held at the Algarve International Circuit.

Tim Hunt, Commercial and Marketing Director for Williams Racing said: “The launch of Dorilton Ventures is extremely exciting, and we are looking forward to helping create sustained growth across the investments and companies they are working with. Our new commercial proposition is already beginning to reap rewards for our partners, and we are eager to begin supporting the companies Dorilton Ventures invests in to deliver similar success.”

Matthew Savage, Dorilton’s co-founder and Chairman added: “Dorilton Ventures brings the strength of the Dorilton team and our approach – investing capital, time and expertise in long-term partnership with management – into the venture market. Our investments are not time-limited, nor are we subject to the concentration limits faced by many venture capital funds. The new commercial direction that has been established at Williams will play a valuable role in helping deliver greater returns on these investments, along with creating outlets for the use of the technologies developed by these companies.”